Bergamottin (a natural LXRα agonist) upregulates ABCA1 transporter activity, enhancing cholesterol efflux and reducing intracellular lipid droplet accumulation in hepatoma cells [76]. Here, NR1H3 is linked to hepatocellular carcinoma.